Cantor Fitzgerald Initiates Coverage On Bicara Therapeutics with Overweight Rating

Benzinga · 10/08 14:58
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Bicara Therapeutics (NASDAQ:BCAX) with a Overweight rating.